ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2025
Oral Semaglutide as an Opportunity for an Appropriate Therapeutic Switch in People with Type 2 Diabetes: A Delphi Consensus.
Matteo Bruglia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.